Dixon S, Booth A, Perrett K
Sheffield Centre for Health and Related Research, University of Sheffield.
J Public Health Med. 1997 Sep;19(3):307-12. doi: 10.1093/oxfordjournals.pubmed.a024635.
Despite the current drive towards evidence-based medicine, it is not clear how commissioners actually use research findings in making decisions on priority setting. This study describes an attempt to directly introduce evidence on the effectiveness of interventions into the annual priority setting process of a District Health Authority (DHA).
Literature searches were undertaken on proposals for Health Authority funding. The identified literature was then critically appraised, and relevant information was used by members of the Department of Public Health to score the individual bids in terms of health gain. These scores were then fed into the priority setting process.
A total of 144 proposals for funding were submitted. For 6.2 per cent of proposals there was strong evidence to support the intervention, for 21.2 per cent there was fair evidence in support, and for 38.1 per cent there was poor evidence. A search was not possible for 16.8 per cent of the proposals. There was a moderate correlation between the strength of evidence for the effectiveness of the proposal and initial scoring of the proposal for health gain (r = 0.41, p < 0.001). At the end of the priority setting process there was no correlation between strength of evidence and priority ranking (r = 0.01, p = 0.97).
It is feasible, but difficult, to use information resources and critical assessment of research evidence as part of the priority setting process of a DHA. The research evidence did appear to influence the initial assessment of proposals. However, the strength of the research evidence was not associated with the priority choices made by the DHA in its purchasing plan.
尽管当前正推动循证医学发展,但尚不清楚决策者在确定优先事项的决策过程中实际如何运用研究结果。本研究描述了一次尝试,即将关于干预措施有效性的证据直接引入地区卫生局(DHA)的年度优先事项确定过程。
针对卫生局的资金提案进行文献检索。然后对所确定的文献进行严格评估,公共卫生部成员利用相关信息根据健康收益对各个投标进行评分。这些分数随后被纳入优先事项确定过程。
共提交了144项资金提案。6.2%的提案有强有力的证据支持该干预措施,21.2%有合理证据支持,38.1%证据不足。16.8%的提案无法进行检索。提案有效性的证据强度与提案的健康收益初始评分之间存在中等程度的相关性(r = 0.41,p < 0.001)。在优先事项确定过程结束时,证据强度与优先排名之间无相关性(r = 0.01,p = 0.97)。
将信息资源和对研究证据的批判性评估作为DHA优先事项确定过程的一部分是可行的,但存在困难。研究证据似乎确实影响了对提案的初始评估。然而,研究证据的强度与DHA在其采购计划中做出的优先选择无关。